HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antidepressant use and salivary cortisol in depressive and anxiety disorders.

Abstract
Antidepressants are an effective treatment for depressive and anxiety disorders. Those disorders are frequently accompanied by heightened cortisol levels. Antidepressants may affect hypothalamic-pituitary-adrenal axis functioning, the alteration of which could be partially responsible for treatment efficacy. The association between antidepressants and cortisol was investigated in 1526 subjects of the Netherlands Study of Depression and Anxiety who were grouped into 'serotonin reuptake inhibitor (SSRI) users' (n=309), 'tricyclic antidepressant (TCA) users' (n=49), 'other antidepressant users' (n=100), and 'non-users' (n=1068). All subjects had a current or past diagnosis of anxiety and/or depression. Subjects provided 7 saliva samples from which 3 cortisol indicators were calculated: cortisol awakening response (CAR), evening cortisol, and cortisol suppression after ingestion of 0.5mg dexamethasone. As compared to non-users, TCA users had a flattened CAR (effect size: Cohen's d=0.34); SSRI users had higher evening cortisol levels (d=0.04); and SSRI users showed decreased cortisol suppression after dexamethasone ingestion (d=0.03). These findings suggest that antidepressant subtypes are associated with distinct alterations of the HPA axis. TCA users, who showed a flattened CAR, displayed the strongest alterations of salivary cortisol.
AuthorsLeonie Manthey, Caroline Leeds, Erik J Giltay, Tineke van Veen, Sophie A Vreeburg, Brenda W J H Penninx, Frans G Zitman
JournalEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology (Eur Neuropsychopharmacol) Vol. 21 Issue 9 Pg. 691-9 (Sep 2011) ISSN: 1873-7862 [Electronic] Netherlands
PMID21458959 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier B.V. and ECNP. All rights reserved.
Chemical References
  • Antidepressive Agents
  • Glucocorticoids
  • Dexamethasone
  • Hydrocortisone
Topics
  • Adult
  • Antidepressive Agents (classification, therapeutic use)
  • Anxiety Disorders (drug therapy, physiopathology)
  • Cohort Studies
  • Depression
  • Depressive Disorder (drug therapy, physiopathology)
  • Dexamethasone (pharmacology)
  • Female
  • Glucocorticoids (pharmacology)
  • Humans
  • Hydrocortisone (analysis)
  • Hypothalamo-Hypophyseal System
  • Longitudinal Studies
  • Male
  • Netherlands
  • Pituitary-Adrenal System (metabolism)
  • Psychiatric Status Rating Scales
  • Saliva (chemistry)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: